Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3KRR

Crystal Structure of JAK2 complexed with a potent quinoxaline ATP site inhibitor

3KRR の概要
エントリーDOI10.2210/pdb3krr/pdb
分子名称Tyrosine-protein kinase JAK2, 8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]-2-(1-piperidin-4-yl-1H-pyrazol-4-yl)quinoxaline (3 entities in total)
機能のキーワードsmall molecule inhibitor, atp site kinase inhibitor, atp-binding, disease mutation, kinase, membrane, nucleotide-binding, phosphoprotein, proto-oncogene, sh2 domain, transferase, tyrosine-protein kinase
由来する生物種Homo sapiens (human)
細胞内の位置Endomembrane system; Peripheral membrane protein (By similarity): O60674
タンパク質・核酸の鎖数1
化学式量合計35213.03
構造登録者
Tavares, G.A.,Gerspacher, M.,Kroemer, M.,Scheufler, C. (登録日: 2009-11-19, 公開日: 2010-07-21, 最終更新日: 2011-07-13)
主引用文献Baffert, F.,Regnier, C.H.,De Pover, A.,Pissot-Soldermann, C.,Tavares, G.A.,Blasco, F.,Brueggen, J.,Chene, P.,Drueckes, P.,Erdmann, D.,Furet, P.,Gerspacher, M.,Lang, M.,Ledieu, D.,Nolan, L.,Ruetz, S.,Trappe, J.,Vangrevelinghe, E.,Wartmann, M.,Wyder, L.,Hofmann, F.,Radimerski, T.
Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805
Mol.Cancer Ther., 9:1945-1955, 2010
Cited by
PubMed: 20587663
DOI: 10.1158/1535-7163.MCT-10-0053
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.8 Å)
構造検証レポート
Validation report summary of 3krr
検証レポート(詳細版)ダウンロードをダウンロード

219140

件を2024-05-01に公開中

PDB statisticsPDBj update infoContact PDBjnumon